C4 Therapeutics, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $55.9M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.3M | 2.4% |
| Other Investing | $271.0K | 0.5% |
| Net Cash Flow | $54.2M | 97.1% |
Net Cash Flow Breakdown
Total Cash from Operations: $55.9M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.3M | 2.4% |
| Other Investing | $271.0K | 0.5% |
| Net Cash Flow | $54.2M | 97.1% |